SEC Form 4 · accession 0001209191-16-115915
CEPHEID · CPHD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
John L Bishop
Officer — Chairman of the Board and CEO · Director
Period of report
Apr 25, 2016
Accepted (ET)
Apr 27, 2016 · 4:18 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001037760
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Apr 25, 2016 | M | 110,000 | $8.43 | A | 194,449 | D | |
| Common StockF2 | Apr 25, 2016 | S | 110,000 | $35.4984 | D | 84,449 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy)F3 | $8.43 | Apr 25, 2016 | M | 110,000 | D | Apr 28, 2010 | Apr 28, 2016 | Common Stock | 110,000 | 0 | D |
| Employee Stock Option (Right to Buy)F3 | $35.94 | Apr 25, 2016 | A | 150,000 | A | Apr 25, 2017 | Apr 25, 2023 | Common Stock | 150,000 | 150,000 | D |
Explanation of responses
- F1The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person.
- F2The sales price reported is the weighted average sale price for the number of shares sold. Full information regarding the number of shares sold at each separate price will be supplied upon request by the Securities & Exchange Commission staff, the Issuer or a security holder of the Issuer.
- F325% of the shares subject to the grant vest and become exercisable on the one-year anniversary of the grant date, then 2.0833% of the shares subject to the grant vest and become exercisable each month thereafter, until such time as the option is 100% vested, subject to the continuing employment of the Reporting Person on each vesting date.